Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7674249
Gels with predetermined conductivity used in electroporation of tissue
granted patentUS 7670599
YKL-40 as a marker and prognostic indicator for cancers
granted patentUS 7670855
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy
granted patentUS 7666886
Compounds and methods for the diagnosis and treatment of amyloid associated diseases
granted patentUS 7662780
Administering hypocretin to obese individuals
granted patentUS 7662910
Inhibitors for the soluble epoxide hydrolase
granted patentUS 7659371
Patched polypeptides and uses related thereto
granted patentUS 7655695
Illudin analogs useful as anticancer agents
granted patentUS 7655472
Treatment of disease by inducing cell apoptosis
granted patentUS 7652001
Pharmacologically active agents containing esterified phosphonates and methods for use the
granted patentUS 7651707
Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with
granted patentUS 7651845
Method and apparatus for glucose control and insulin dosing for diabetics
granted patentUS 7651847
Methods of oligosaccharide profiling for the detection of cancer
granted patentUS 7648826
Detecting CYP24 expression level as a marker for predisposition to cancer
granted patentUS 7645885
Non-steroidal antiandrogens
granted patentUS 7642280
Inhibitors of acyl glucosaminyl inositol amidase and methods of use
granted patentUS 7638300
In vivo incorporation of unnatural amino acids
granted patentUS 7638501
Method of treatment of mitochondrial disorders
granted patentUS 7638494
G-type peptides to ameliorate atherosclerosis
granted patentUS 7638269
Viral capsid assembly intermediates and methods of production
granted patentUS 7638640
Purifications of pomegranate ellagitannins and their uses thereof
granted patentUS 7638543
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
granted patentUS 7635712
Salinosporamides and methods for use thereof
granted patentUS 7632814
HYD1 peptides as anti-cancer agents
granted